Cargando…
Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
BACKGROUND: A single low dose (0.25 mg/kg) of primaquine is recommended as a gametocytocide in combination with artemisinin-based combination therapies for Plasmodium falciparum but its effect on post-treatment gametocyte circulation and infectiousness to mosquitoes has not been quantified. METHODS:...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782330/ https://www.ncbi.nlm.nih.gov/pubmed/26952094 http://dx.doi.org/10.1186/s12916-016-0581-y |
_version_ | 1782419931357249536 |
---|---|
author | Gonçalves, Bronner P. Tiono, Alfred B. Ouédraogo, Alphonse Guelbéogo, Wamdaogo M. Bradley, John Nebie, Issa Siaka, Débé Lanke, Kjerstin Eziefula, Alice C. Diarra, Amidou Pett, Helmi Bougouma, Edith C. Sirima, Sodiomon B. Drakeley, Chris Bousema, Teun |
author_facet | Gonçalves, Bronner P. Tiono, Alfred B. Ouédraogo, Alphonse Guelbéogo, Wamdaogo M. Bradley, John Nebie, Issa Siaka, Débé Lanke, Kjerstin Eziefula, Alice C. Diarra, Amidou Pett, Helmi Bougouma, Edith C. Sirima, Sodiomon B. Drakeley, Chris Bousema, Teun |
author_sort | Gonçalves, Bronner P. |
collection | PubMed |
description | BACKGROUND: A single low dose (0.25 mg/kg) of primaquine is recommended as a gametocytocide in combination with artemisinin-based combination therapies for Plasmodium falciparum but its effect on post-treatment gametocyte circulation and infectiousness to mosquitoes has not been quantified. METHODS: In this randomised, double-blind, placebo-controlled trial, 360 asymptomatic parasitaemic children aged 2-15 years were enrolled and assigned to receive: artemether-lumefantrine (AL) and a dose of placebo; AL and a 0.25 mg/kg primaquine dose; or AL and a 0.40 mg/kg primaquine dose. On days 0, 2, 3, 7, 10 and 14, gametocytes were detected and quantified by microscopy, Pfs25 mRNA quantitative nucleic acid sequence based amplification (QT-NASBA), and quantitative reverse-transcriptase PCR (qRT-PCR). For a subset of participants, pre- and post-treatment infectiousness was assessed by mosquito feeding assays on days -1, 3, 7, 10 and 14. RESULTS: Both primaquine arms had lower gametocyte prevalences after day 3 compared to the placebo arm, regardless of gametocyte detection method. The mean (95 % confidence interval) number of days to gametocyte clearance in children with patent gametocytes on day 0 (N = 150) was 19.7 (14.6 – 24.8), 7.7 (6.3 – 9.1) and 8.2 (6.7 – 9.6) for the AL-placebo, the 0.25 mg/kg primaquine dose and the 0.40 mg/kg primaquine dose arms, respectively. While 38.0 % (30/79) of selected gametocytaemic individuals were infectious before treatment, only 1/251 participant, from the AL-placebo group, infected mosquitoes after treatment. CONCLUSIONS: We observed similar gametocyte clearance rates after 0.25 and 0.40 mg/kg primaquine doses. Infectivity to mosquitoes after AL was very low and absent in primaquine arms. CLINICALTRIALS.GOV REGISTRATION: NCT01935882 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0581-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4782330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47823302016-03-09 Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial Gonçalves, Bronner P. Tiono, Alfred B. Ouédraogo, Alphonse Guelbéogo, Wamdaogo M. Bradley, John Nebie, Issa Siaka, Débé Lanke, Kjerstin Eziefula, Alice C. Diarra, Amidou Pett, Helmi Bougouma, Edith C. Sirima, Sodiomon B. Drakeley, Chris Bousema, Teun BMC Med Research Article BACKGROUND: A single low dose (0.25 mg/kg) of primaquine is recommended as a gametocytocide in combination with artemisinin-based combination therapies for Plasmodium falciparum but its effect on post-treatment gametocyte circulation and infectiousness to mosquitoes has not been quantified. METHODS: In this randomised, double-blind, placebo-controlled trial, 360 asymptomatic parasitaemic children aged 2-15 years were enrolled and assigned to receive: artemether-lumefantrine (AL) and a dose of placebo; AL and a 0.25 mg/kg primaquine dose; or AL and a 0.40 mg/kg primaquine dose. On days 0, 2, 3, 7, 10 and 14, gametocytes were detected and quantified by microscopy, Pfs25 mRNA quantitative nucleic acid sequence based amplification (QT-NASBA), and quantitative reverse-transcriptase PCR (qRT-PCR). For a subset of participants, pre- and post-treatment infectiousness was assessed by mosquito feeding assays on days -1, 3, 7, 10 and 14. RESULTS: Both primaquine arms had lower gametocyte prevalences after day 3 compared to the placebo arm, regardless of gametocyte detection method. The mean (95 % confidence interval) number of days to gametocyte clearance in children with patent gametocytes on day 0 (N = 150) was 19.7 (14.6 – 24.8), 7.7 (6.3 – 9.1) and 8.2 (6.7 – 9.6) for the AL-placebo, the 0.25 mg/kg primaquine dose and the 0.40 mg/kg primaquine dose arms, respectively. While 38.0 % (30/79) of selected gametocytaemic individuals were infectious before treatment, only 1/251 participant, from the AL-placebo group, infected mosquitoes after treatment. CONCLUSIONS: We observed similar gametocyte clearance rates after 0.25 and 0.40 mg/kg primaquine doses. Infectivity to mosquitoes after AL was very low and absent in primaquine arms. CLINICALTRIALS.GOV REGISTRATION: NCT01935882 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0581-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-08 /pmc/articles/PMC4782330/ /pubmed/26952094 http://dx.doi.org/10.1186/s12916-016-0581-y Text en © Gonçalves et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Gonçalves, Bronner P. Tiono, Alfred B. Ouédraogo, Alphonse Guelbéogo, Wamdaogo M. Bradley, John Nebie, Issa Siaka, Débé Lanke, Kjerstin Eziefula, Alice C. Diarra, Amidou Pett, Helmi Bougouma, Edith C. Sirima, Sodiomon B. Drakeley, Chris Bousema, Teun Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial |
title | Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial |
title_full | Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial |
title_fullStr | Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial |
title_full_unstemmed | Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial |
title_short | Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial |
title_sort | single low dose primaquine to reduce gametocyte carriage and plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782330/ https://www.ncbi.nlm.nih.gov/pubmed/26952094 http://dx.doi.org/10.1186/s12916-016-0581-y |
work_keys_str_mv | AT goncalvesbronnerp singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT tionoalfredb singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT ouedraogoalphonse singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT guelbeogowamdaogom singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT bradleyjohn singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT nebieissa singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT siakadebe singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT lankekjerstin singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT eziefulaalicec singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT diarraamidou singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT petthelmi singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT bougoumaedithc singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT sirimasodiomonb singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT drakeleychris singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial AT bousemateun singlelowdoseprimaquinetoreducegametocytecarriageandplasmodiumfalciparumtransmissionafterartemetherlumefantrineinchildrenwithasymptomaticinfectionarandomiseddoubleblindplacebocontrolledtrial |